Science Explorer Back to mapMap
Discussion
Institution · Jubilant Life Sciences (India)

Most cited papers from Jubilant Life Sciences (India)

Jubilant Life Sciences (India)

What are the most cited papers from Jubilant Life Sciences (India)?

The most cited paper from Jubilant Life Sciences (India) is "Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics" (Dolly Sharma, Mamta Singh, Reshma Rani, 2022), with 455 citations. Next come "An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity" (453) and "Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir" (234).

Showing 50 of 60 papers. Every paper with more than 47 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics Dolly Sharma, Mamta Singh, Reshma Rani · Seminars in Cancer Biology 9 Nov 2022 455
2 An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity David J. Haydon, Neil R. Stokes, Rebecca Ure et al. · Science Open access 18 Sep 2008 453
3 Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir Shilpi Sinha, Mushir Ali, Sanjula Baboota et al. · AAPS PharmSciTech Open access 17 Mar 2010 234
4 Regio‐ and Chemoselective Reduction of Nitroarenes and Carbonyl Compounds over Recyclable Magnetic FerriteNickel Nanoparticles (Fe3O4Ni) by Using Glycerol as a Hydrogen Source Manoj B. Gawande, Anuj Kumar Rathi, Paula S. Branco et al. · Chemistry - A European Journal 30 Aug 2012 190
5 Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics? Mamta Singh, Julieta Afonso, Dolly Sharma et al. · Seminars in Cancer Biology 24 Jan 2023 187
6 Magnetite-supported sulfonic acid: a retrievable nanocatalyst for the Ritter reaction and multicomponent reactions Manoj B. Gawande, Anuj Kumar Rathi, Isabel Nogueira et al. · Green Chemistry 2013 187
7 Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives Ramesh Mullangi, Preeti Ahlawat, Nuggehally R. Srinivas · Biomedical Chromatography 23 Oct 2009 181
8 Purple heart plant leaves extract-mediated silver nanoparticle synthesis: Optimization by Box-Behnken design Md Saquib Hasnain, Md. Noushad Javed, Md Sabir Alam et al. · Materials Science and Engineering C 15 Feb 2019 178
9 Medicinal importance, pharmacological activities, and analytical aspects of hispidulin: A concise report Kanika Patel, Dinesh Kumar Patel · Journal of Traditional and Complementary Medicine Open access 10 Dec 2016 172
10 GSK3β: role in therapeutic landscape and development of modulators Samiron Phukan, V. Venkatesh Babu, Akanksha Kannoji et al. · British Journal of Pharmacology Open access 20 Mar 2010 158
11 TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders Atul Kumar Tiwari, Pranab Maiti · Drug Discovery Today 26 Feb 2009 120
12 Implication of Nano-Antioxidant Therapy for Treatment of Hepatocellular Carcinoma Using PLGA Nanoparticles of Rutin Preeti Madhuri Pandey, Mahfoozur Rahman, Prakash Chandra Bhatt et al. · Nanomedicine 22 Mar 2018 116
13 CREB is a critical regulator of normal hematopoiesis and leukemogenesis Jerry C. Cheng, Kentaro Kinjo, Dejah R. Judelson et al. · Blood Open access 2 Nov 2007 115
14 Glioblastoma: Current Status, Emerging Targets, and Recent Advances Amandeep Thakur, Chetna Faujdar, Ram Sharma et al. · Journal of Medicinal Chemistry Open access 5 Jul 2022 114
15 High yield synthesis of amine functionalized graphene oxide and its surface properties Souvik Chakraborty, Saikat Saha, V.R. Dhanak et al. · RSC Advances 2016 107
16 Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors Victor S. Gehling et al. · ACS Medicinal Chemistry Letters Open access 16 Jul 2013 105
17 Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties David J. Haydon, James M. Bennett, David Richard Brown et al. · Journal of Medicinal Chemistry Open access 28 Apr 2010 105
18 A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders Aimo Kannt et al. · Scientific Reports Open access 20 Feb 2018 102
19 Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation Adnan Azeem, Sushama Talegaonkar, Lalit Mohan Singh Negi et al. · International Journal of Pharmaceutics 27 Oct 2011 98
20 An Improved Small-Molecule Inhibitor of FtsZ with Superior In Vitro Potency, Drug-Like Properties, and In Vivo Efficacy Neil R. Stokes, Nicola Baker, James M. Bennett et al. · Antimicrobial Agents and Chemotherapy Open access Nov 2012 98
21 Sustainable Utility of Magnetically Recyclable Nano-Catalysts in Water: Applications in Organic Synthesis Manoj B. Gawande, Anuj Kumar Rathi, Paula S. Branco et al. · Applied Sciences Open access 25 Oct 2013 96
22 First application of core-shell Ag@Ni magnetic nanocatalyst for transfer hydrogenation reactions of aromatic nitro and carbonyl compounds Manoj B. Gawande, Huizhang Guo, Anuj Kumar Rathi et al. · RSC Advances 15 Nov 2012 93
23 PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis Sindhu Koushik, Nivedita Joshi, Shruthi Nagaraju et al. · Expert Opinion on Therapeutic Targets 16 Feb 2017 86
24 Could MM-GBSA be accurate enough for calculation of absolute protein/ligand binding free energies? Chandrika Mulakala, Vellarkad N. Viswanadhan · Journal of Molecular Graphics and Modelling 18 Sep 2013 86
25 A Recyclable Ferrite–Co Magnetic Nanocatalyst for the Oxidation of Alcohols to Carbonyl Compounds Manoj B. Gawande, Anuj Kumar Rathi, Isabel Nogueira et al. · ChemPlusChem 10 Aug 2012 84
26 GLUT and HK: Two primary and essential key players in tumor glycolysis Dhiraj Yadav, Anubha Yadav, Sujata Bhattacharya et al. · Seminars in Cancer Biology 15 Mar 2024 82
27 New insights into the medicinal importance, physiological functions and bioanalytical aspects of an important bioactive compound of foods ‘Hyperin’: Health benefits of the past, the present, the future Kanika Patel, Vikas Kumar, Mahfoozur Rahman et al. · Beni-Suef University Journal of Basic and Applied Sciences Open access Jun 2017 82
28 Design, synthesis and structure–activity relationships of substituted oxazole–benzamide antibacterial inhibitors of FtsZ Neil R. Stokes et al. · Bioorganic & Medicinal Chemistry Letters 13 Nov 2013 80
29 Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides Atul T. Manvar, Alpeshkumar K. Malde, Jitender Kumar Verma et al. · European Journal of Medicinal Chemistry 31 Jan 2008 79
30 PLK4: a link between centriole biogenesis and cancer Radhika Radha Maniswami, Seema Prashanth, Archana Venkataramana Karanth et al. · Expert Opinion on Therapeutic Targets 24 Nov 2017 75
31 Emerging role of SETDB1 as a therapeutic target Archana Venkataramana Karanth, Radhika Radha Maniswami, Seema Prashanth et al. · Expert Opinion on Therapeutic Targets 11 Jan 2017 72
32 Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4 Chandru Gajendran, Shoichi Fukui, Naveen M. Sadhu et al. · Scientific Reports Open access 23 Feb 2023 69
33 A comprehensive study on regulatory requirements for development and filing of generic drugs globally Shweta Handoo, Deepak Khera, PrafullaKumar Nandi et al. · International Journal of Pharmaceutical Investigation Open access 2012 69
34 SIGNAL TRANSDUCTION PATHWAYS LINKING THE ACTIVATION OF ALVEOLAR MACROPHAGES WITH THE RECRUITMENT OF NEUTROPHILS TO LUNGS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE Vidyasaral Murugan, Michael J. Peck · Experimental Lung Research 2009 68
35 MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit Robert A. Volkmann, Christopher M. Fanger, David R. Anderson et al. · PLoS ONE Open access Feb 2016 65
36 The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470) Chafiq Hamdouchi et al. · Journal of Medicinal Chemistry Open access 17 Oct 2016 62
37 Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer Md. Abul Barkat, Harshita, Javed Ahmad et al. · Current Drug Targets 5 Jan 2018 60
38 Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC‐MS/MS and its application to a human pharmacokinetic study Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, Ramesh Mullangi et al. · Biomedical Chromatography 13 Jul 2010 60
39 Soluble starch-blended Ca 2+ -Zn 2+ -alginate composites-based microparticles of aceclofenac: Formulation development and in vitro characterization Amit Kumar Nayak, Jadupati Malakar, Dilipkumar Pal et al. · Future Journal of Pharmaceutical Sciences Open access 18 Mar 2018 59
40 Identification of Allosteric PIF‐Pocket Ligands for PDK1 using NMR‐Based Fragment Screening and 1H‐15N TROSY Experiments Brian J. Stockman, Michael Kothe, Darcy Kohls et al. · Chemical Biology & Drug Design 22 Jan 2009 58
41 Emergence in the functionalized carbon nanotubes as smart nanocarriers for drug delivery applications Sarwar Beg, Mahfoozur Rahman, Atul Jain et al. · Elsevier eBooks Book chapterOpen access 2018 57
42 Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents Edward A. Kesicki, Mai Ann Bailey, Yulia Ovechkina et al. · PLoS ONE Open access 12 May 2016 57
43 Nanosuspension-Based Aloe vera Gel of Silver Sulfadiazine with Improved Wound Healing Activity Md. Abul Barkat, Harshita, Iqbal Ahmad et al. · AAPS PharmSciTech 5 Jun 2017 56
44 The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents Edison S. Zuniga, Aaron Korkegian, Steven F. Mullen et al. · Bioorganic & Medicinal Chemistry Open access 19 May 2017 56
45 Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors – review of assay methodologies and perspectives Kuldeep Kumar Sharma, P. S. Suresh, Ramesh Mullangi et al. · Biomedical Chromatography 26 Nov 2014 56
46 A classification model for blood brain barrier penetration Manvi Singh, Reshmi Divakaran, Leela Sarath Kumar Konda et al. · Journal of Molecular Graphics and Modelling 20 Dec 2019 55
47 High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N -Methyltransferase (NNMT) Rocco L. Policarpo, Ludovic Decultot, Elizabeth May et al. · Journal of Medicinal Chemistry Open access 7 Oct 2019 55
48 Silica gel promoted environment-friendly synthesis of 2,3-disubstituted 4-thiazolidinones Manoj P. Thakare, Puneet Kumar, Naresh Kumar et al. · Tetrahedron Letters 11 Mar 2014 54
49 Development and validation of a highly sensitive and robust LC‐ESI‐MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study Addepalli Venkata Ramani, Pinaki Sengupta, Ramesh Mullangi · Biomedical Chromatography 10 Mar 2009 54
50 Pose Prediction Accuracy in Docking Studies and Enrichment of Actives in the Active Site of GSK-3β Pravin Kumar Gadakar, Samiron Phukan, and Prasanna Dattatreya et al. · Journal of Chemical Information and Modeling 20 Jun 2007 53

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.